Evidence map›Paper›PMID 40779149›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Development and validation of a transformer-based deep learning model for predicting distant metastasis in non-small cell lung cancer using

Na Hu, Yunpeng Luo, Maowen Tang, Gang Yan, Shengmei Yuan, Fangyan Li, Pinggui Lei

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Na Hu *Department of Radiology, The Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang, 550004, China.
Yunpeng Luo *Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Maowen Tang *Department of Radiology, The Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang, 550004, China.
Gang YanDepartment of Nuclear Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Shengmei YuanDepartment of Ultrasound Center, Affliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Fangyan LiDepartment of Radiology, The Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang, 550004, China.
Pinggui LeiDepartment of Radiology, The Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, Guiyang, 550004, China. pingguilei@foxmail.com.ORCID http://orcid.org/0000-0001-7610-0292

Funding

Guizhou Medical University Affiliated Hospital National Natural Science Foundation of China (NSFC) Youth Fund Cultivation Program Project gyfynsfc[2023]-07Science and Technology Projects of Guizhou Province Qiankehejichu-ZK[2022]422Youth Science and Technology Talent Growth Project of Guizhou Ordinary Colleges and Universities Qianjiaohe KYZ[2022]No.212)
6 · The paper itself

Abstract

backgroundThis study aimed to develop and validate a hybrid deep learning (DL) model that integrates convolutional neural network (CNN) and vision transformer (ViT) architectures to predict distant metastasis (DM) in patients with non-small cell lung cancer (NSCLC) using

methodsA retrospective analysis was conducted on a cohort of consecutively registered patients who were newly diagnosed and untreated for NSCLC. A total of 167 patients with available PET/CT images were included in the analysis. DL features were extracted using a combination of CNN and ViT architectures, followed by feature selection, model construction, and evaluation of model performance using the receiver operating characteristic (ROC) and the area under the curve (AUC).

resultsThe ViT-based DL model exhibited strong predictive capabilities in both the training and validation cohorts, achieving AUCs of 0.824 and 0.830 for CT features, and 0.602 and 0.694 for PET features, respectively. Notably, the model that integrated both PET and CT features demonstrated a notable AUC of 0.882 in the validation cohort, outperforming models that utilized either PET or CT features alone. Furthermore, this model outperformed the CNN model (ResNet 50), which achieved an AUC of 0.752 [95% CI 0.613, 0.890], p < 0.05. Decision curve analysis further supported the efficacy of the ViT-based DL model.

conclusionThe ViT-based DL developed in this study demonstrates considerable potential in predicting DM in patients with NSCLC, potentially informing the creation of personalized treatment strategies. Future validation through prospective studies with larger cohorts is necessary.

Indexed as

Carcinoma, Non-Small-Cell LungDeep LearningNeoplasm MetastasisAgedConvolutional Neural NetworksFemaleForecastingHumansImage Interpretation, Computer-AssistedMaleMiddle AgedPositron Emission Tomography Computed TomographyRetrospective Studies18F-ffuorodeoxyglucose uptake on positron emission tomography/computed tomographyConvolutional neural networkDeep learningDistant metastasisNon-small cell lung cancerVision transformer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.